Empirical evidence of abnormal microglial activity in schizophrenia derives from post-mortem neuropathological studies and in vivo positron emission tomography (PET) with a ligand of the 18kDA translocator protein (TSPO) (De Picker et al., 2017). The gene discussed is TSPO; the disease is schizophrenia.